2023
Entrant Company
Category
Client's Name
Country / Region
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant Company
5WPR
Category
Website - Educational / Training
Country / Region
United States
Entrant Company
MI Health Agency
Category
Video, Commercial & Film - Documentary
Country / Region
Ukraine
Entrant Company
Love Communications
Category
Integrated Marketing - Product Branding
Country / Region
United States
Entrant Company
Freelance
Category
Mobile Apps & Softwares - User Experience
Country / Region
Canada